HR 1199
118th Congress
House
Health
Health care costs and insurance
Medical tests and diagnostic methods
Medicare
Radiation
Facilitating Innovative Nuclear Diagnostics Act of 2023
Everywhere this bill has been
5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 16, 2024
Forwarded by Subcommittee to Full Committee by Voice Vote.
May 16, 2024
Subcommittee Consideration and Mark-up Session Held
Mar 10, 2023
Referred to the Subcommittee on Health.
Feb 27, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 27, 2023
Introduced in House
Plain-English summary
Facilitating Innovative Nuclear Diagnostics Act of 2023
This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2024 and as adjusted based on a specified fee schedule factor in each year thereafter.
What's happening now
Forwarded by Subcommittee to Full Committee by Voice Vote.
Committees of jurisdiction
3